Eduardo
Larequi Ardanáz
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (11)
2023
-
A Multimodal Scaffold for SDF1 Delivery Improves Cardiac Function in a Rat Subacute Myocardial Infarct Model
ACS Applied Materials and Interfaces, Vol. 15, Núm. 44, pp. 50638-50651
-
Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p.Ser43Asn mutation in the TTR gene
Stem Cell Research, Vol. 71
-
Generation of heart and vascular system in rodents by blastocyst complementation
Developmental Cell, Vol. 58, Núm. 24, pp. 2881-2895.e7
2022
-
Comparative Evaluation of Inducible Cre Mouse Models for Fibroblast Targeting in the Healthy and Infarcted Myocardium
Biomedicines, Vol. 10, Núm. 10
2021
2020
-
Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors
Journal of Tissue Engineering and Regenerative Medicine, Vol. 14, Núm. 1, pp. 123-134
2019
-
Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4–induced M2 macrophage polarization
FASEB Journal, Vol. 33, Núm. 6, pp. 7578-7587
2017
-
Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury
Journal of Translational Medicine, Vol. 15, Núm. 1
2014
-
Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
Journal of Hepatology, Vol. 60, Núm. 5, pp. 1017-1025
-
Cardiotrophin-1 stimulates lipolysis through the regulation of main adipose tissue lipases
Journal of Lipid Research, Vol. 55, Núm. 12, pp. 2634-2643
2011
-
Cardiotrophin-1 is a key regulator of glucose and lipid metabolism
Cell Metabolism, Vol. 14, Núm. 2, pp. 242-253